Significance of Synbiotics on Inflammation and Proliferation of Colonic Mucosa
- Conditions
- Inflammation
- Interventions
- Dietary Supplement: LactobacillusDietary Supplement: Bifidobacterium
- Registration Number
- NCT01534572
- Lead Sponsor
- Region Skane
- Brief Summary
There is a constant exchange between the gut epithelium and lumen, including microbial interplay. The aim of this study was to investigate dietary test products on inflammatory proliferation markers in the gut, and thereby if the products had positive effects in the gut as well as in other parts of the body.
The hypothesis was that the test products would reduce the inflammatory and proliferation activity of the gut epithelium by fermentation of normal food products and by converting dietary phenolic compounds into anti-inflammatory substances.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 12
- 18-80 years old,
- Able to understand oral and written information,
- Informed consent
- Ongoing immune suppressive treatment, incl. cortisone,
- Ongoing antibiotic treatment or antibiotic treatment ended within 4 weeks,
- History of inflammatory bowel disease
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Probiotics_Lactobacillus Lactobacillus Intervention (2 weeks) with a strain of Lactobacillus Probiotics_Bifidobacterium Bifidobacterium Intervention (2 weeks) of daily supplementation of a probiotic strain of Bifidobacterium.
- Primary Outcome Measures
Name Time Method Reactivity of rectal mucosa after 2 weeks intervention to study the reactivity of rectal mucosa after a standardized inflammatory insult before and after treatment with probiotics
- Secondary Outcome Measures
Name Time Method influence on immune system after 2 weeks intervention to study the influence on systemic leukocytes and regulatory T cells